International Journal of Hematology

, Volume 91, Issue 2, pp 345–346

Reply to the letter by Bedognetti et al. “Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era”

Letter to the Editor

DOI: 10.1007/s12185-010-0523-y

Cite this article as:
Kusumoto, S. & Tanaka, Y. Int J Hematol (2010) 91: 345. doi:10.1007/s12185-010-0523-y
  • 33 Downloads

Copyright information

© The Japanese Society of Hematology 2010

Authors and Affiliations

  1. 1.Department of Medical Oncology and ImmunologyNagoya City University Graduate School of Medical SciencesNagoyaJapan
  2. 2.Department of VirologyNagoya City University Graduate School of Medical SciencesNagoyaJapan

Personalised recommendations